X-77688876-T-C
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong
The NM_000489.6(ATRX):c.536A>G(p.Asn179Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.536A>G | p.Asn179Ser | missense_variant | Exon 7 of 35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Pathogenic:2
- -
Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000093141, PMID:10995512). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 16813605). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.745>=0.6, SPLICEAI: 0.68). A missense variant is a common mechanism . It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Intellectual disability-hypotonic facies syndrome, X-linked, 1 Pathogenic:2
The hemizygous p.Asn179Ser variant in ATRX was identified by our study in 3 siblings with x-linked mental retardation-hypotonic facies syndrome. This variant is assumed de novo in 1 individual, but maternity and paternity have not been confirmed (PMID: 16813605). The variant has been reported in at least 5 individuals of Japanese and unknown ethnicity with x-linked mental retardation-hypotonic facies syndrome (PMID: 16813605, 10995512, 8968741, 25252072, 33229608), but was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 93141) as pathogenic by GeneDx, HudsonAlpha Institute for Biotechnology, and EGL Genetic Diagnostics, Eurofins Clinical Diagnostics. In vitro functional studies provide some evidence that the p.Asn179Ser variant may slightly impact protein function (PMID: 8968741). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The number of missense variants reported in ATRX in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM6, PP2, PP3, PS4_supporting, PS3_supporting (Richards 2015). -
- -
not provided Pathogenic:2
The c.536 A>G pathogenic variant in the ATRX gene has been reported previously in association with ATRX-related disorders (Picketts et al., 1996; Badens et al., 2006; Wada et al., 2000). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Functional studies indicate that c.536 A>G creates a cryptic splice donor site, leading to a deletion of 63 nucleotides (reported as A751G using alternate nomenclature in Villard et al., 1997; reported as A869G using alternate nomenclature in Picketts et al., 1996). This substitution occurs in the ADD domain and pathogenic variants affecting this domain are presumed to have structural consequences on the ATRX protein and impact histone methylation (Argentaro et al., 2007; Iwase et al., 2011; Stenson et al., 2014). -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at